Journal of Immunology Research / 2015 / Article / Tab 2

Review Article

Peptide-Based Treatment: A Promising Cancer Therapy

Table 2

Peptides applied in treating cancer.

Cancer typePeptideModelYearAuthorReference

Pancreatic cancerWT1In vivo2014Nishida et al.[27]
KIF20AIn vivo2014Suzuki et al.[28]
GV1001In vivo2014Staff et al.[29]

Gastric cancerVEGFR1, 2In vivo2012Masuzawa et al.[30]
LY6K-177In vivo2014Ishikawa et al.[31]

Prostate cancerPAP-114-128TRAMP C12014Saif et al.[32]

Breast cancerp5TUBO2014Mansourian et al.[33]
SU18, SU22In vivo2014Ohtake et al.[34]
E75In vivo2014Mittendorf et al.[35]
ErbB-2MMC2014Gil et al.[36]

Colorectal cancerANPDHD/K12/Trb, SW6202012Serafino et al.[37]
TCP-1HCT116 and HT-292010Li et al.[38]
F56HUVEC2014Wang et al.[39]

NSCLCWT1In vivo2013Takahashi et al. [40]
TERT572YIn vivo2014Kotsakis et al.[41]
DisruptinH19752014 Ahsa et al. [42]

Lung cancerLFC131A5492014Chittasupho et al.[44]
BPPIn vivo2014Wang et al.[45]

MelanomaTH10B16F10-luc-G52014Guan et al.[46]

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.